SALE
市場調查報告書

限制性核酸內切酶的全球市場:至2025年的預測與市場機會

Global Restriction Endonuclease Market By Type, By Application, By End Type, By Source, By Cleavage Specificity, By End-User, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934761
出版日期 內容資訊 英文 116 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

限制性核酸內切酶的全球市場:至2025年的預測與市場機會 Global Restriction Endonuclease Market By Type, By Application, By End Type, By Source, By Cleavage Specificity, By End-User, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 116 Pages
簡介

全球限制性核酸內切酶市場在預測期間內預計將以強勁的年複合成長率成長。市場成長的主要原因,是在生物科技部門和製藥產業等終用途產業的研究開發活動的投資增加。再加上糖尿病,癌症等慢性健康障礙的發生率上升,今後數年將成為全球的限制性核酸內切酶市場成長的徵兆。

本報告提供全球限制性核酸內切酶各市場市場區隔和各地區調查,市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球限制性核酸內切酶市場的影響

第4章 摘要整理

第5章 全球限制性核酸內切酶市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型(I,II,III,IV)
    • 各用途(基因工程學,DNA製圖,遺傳基因序列測定等)
    • 各端類型(黏端,鈍端)
    • 各來源(細菌,古細菌)
    • 各切斷特異性(同裂酶,異裂酶)
    • 各終端用戶(製藥及生物科技企業,學術調查機關等)
    • 各公司(2019年)
    • 各地區
  • 市場魅力指數

第6章 亞太地區的限制性核酸內切酶市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各用途
    • 各端類型
    • 各來源
    • 各切斷特異性
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第7章 歐洲的限制性核酸內切酶市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各用途
    • 各端類型
    • 各來源
    • 各切斷特異性
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章 北美的限制性核酸內切酶市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各用途
    • 各端類型
    • 各來源
    • 各切斷特異性
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 南美的限制性核酸內切酶市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各用途
    • 各端類型
    • 各來源
    • 各切斷特異性
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東、非洲的限制性核酸內切酶市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各用途
    • 各端類型
    • 各來源
    • 各切斷特異性
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第11章 市場動態

  • 促進因素
  • 課題

第12章 市場趨勢與發展

第13章 競爭情形

  • 競爭的展望
  • 主要企業簡介
    • New England Biolabs
    • Thermo Fisher Scientific
    • Takara Bio
    • Sigma-Aldrich
    • Illumina
    • Agilent Technologies
    • Promega
    • Jena Biosciences
    • Genetix Biotech Asia Pvt. Ltd.
    • Roche
    • Merck
    • Pfizer
    • Amgen
    • Vertex Pharmaceuticals
    • BioMarin Pharmaceutical
    • PerkinElmer
    • Abcam
    • Abbexa
    • Sisco Research Laboratories Pvt Ltd
    • Nippon Gene

第14章 策略性推薦事項

第15章 關於免責聲明

目錄
Product Code: 4638

Global restriction endonuclease market is expected to grow at a formidable CAGR during the forecast period. The key factor responsible for market growth is growing investment in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, rising incidences of chronic health disorders like diabetes, cancer among others is anticipated to bode well for the growth of restriction endonuclease market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025.

The global restriction endonuclease market is segmented based on type, application, end type, source, cleavage, end-user, region and company. Based on type, the market can be segmented into Type I, Type II, Type III and Type IV. Out of which, the Type II segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its lead during the forecast years as well. This growth can be accredited to its use in molecular biology applications that are carried on everyday such as gene cloning and DNA fragmentation and analysis. Also, because these enzymes cleave DNA at fixed positions, therefore small, well-defined fragments of DNA are produced which assist in characterization of genes and genomes, thereby anticipated to boost the growth of Type II restriction endonucleases segment over the coming years. Moreover, increasing investments in development activities by biotechnology companies is further aiding the segmental growth.

Major players operating in the global restriction endonuclease market include New England Biolabs, Thermo Fisher Scientific, Takara Bio, Sigma-Aldrich, Illumina, Agilent Technologies, Promega, Jena Biosciences, Genetix Biotech Asia Pvt. Ltd., Roche, Merck, Pfizer, Amgen, Vertex Pharmaceuticals, BioMarin Pharmaceutical, PerkinElmer, Abcam, Abbexa, Sisco Research Laboratories Pvt Ltd, Nippon Gene. The companies operating in restriction endonuclease market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as developing novel technologies in order to meet the requirements of users and to make the industry highly competitive.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global restriction endonuclease market.
  • To classify and forecast global restriction endonuclease market based on type, application, end type, source, cleavage, end-user, company and regional distribution.
  • To identify drivers and challenges for global restriction endonuclease market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global restriction endonuclease market.
  • To conduct pricing analysis for global restriction endonuclease market.
  • To identify and analyse the profile of leading players operating in global restriction endonuclease market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global restriction endonuclease market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Restriction endonuclease companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to restriction endonuclease
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global restriction endonuclease market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:

Type I

Type II

Type III

Type IV

  • Market, By Application:

Genetic Engineering

DNA Mapping

Gene Sequencing

Others

  • Market, By End Type:

Sticky End

Blunt End

  • Market, By Source:

Bacteria

Archaea

  • Market, By Cleavage Specificity:

Isoschizomers

Neoschizomers

  • Market, By End-User:

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Others

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global restriction endonuclease market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Restriction Endonuclease Market

4. Executive Summary

5. Global Restriction Endonuclease Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (I, II, III, IV)
    • 5.2.2. By Application ( Genetic Engineering, DNA Mapping, Gene Sequencing and Others)
    • 5.2.3. By End Type (Sticky End, Blunt End)
    • 5.2.4. By Source (Bacteria, Archaea)
    • 5.2.5. By Cleavage Specificity (Isoschizomers, Neoschizomers)
    • 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others)
    • 5.2.7. By Company (2019)
    • 5.2.8. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Restriction Endonuclease Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End Type
    • 6.2.4. By Source
    • 6.2.5. By Cleavage Specificity
    • 6.2.6. By End-User
    • 6.2.7. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Restriction Endonuclease Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Type
        • 6.4.1.2.2. By Application
        • 6.4.1.2.3. By End Type
        • 6.4.1.2.4. By Source
        • 6.4.1.2.5. By Cleavage Specificity
        • 6.4.1.2.6. By End-User
    • 6.4.2. India Restriction Endonuclease Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Type
        • 6.4.2.2.2. By Application
        • 6.4.2.2.3. By End Type
        • 6.4.2.2.4. By Source
        • 6.4.2.2.5. By Cleavage Specificity
        • 6.4.2.2.6. By End-User
    • 6.4.3. Japan Restriction Endonuclease Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Type
        • 6.4.3.2.2. By Application
        • 6.4.3.2.3. By End Type
        • 6.4.3.2.4. By Source
        • 6.4.3.2.5. By Cleavage Specificity
        • 6.4.3.2.6. By End-User
    • 6.4.4. South Korea Restriction Endonuclease Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Type
        • 6.4.4.2.2. By Application
        • 6.4.4.2.3. By End Type
        • 6.4.4.2.4. By Source
        • 6.4.4.2.5. By Cleavage Specificity
        • 6.4.4.2.6. By End-User
    • 6.4.5. Singapore Restriction Endonuclease Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Type
        • 6.4.5.2.2. By Application
        • 6.4.5.2.3. By End Type
        • 6.4.5.2.4. By Source
        • 6.4.5.2.5. By Cleavage Specificity
        • 6.4.5.2.6. By End-User
    • 6.4.6. Australia Restriction Endonuclease Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Type
        • 6.4.6.2.2. By Application
        • 6.4.6.2.3. By End Type
        • 6.4.6.2.4. By Source
        • 6.4.6.2.5. By Cleavage Specificity
        • 6.4.6.2.6. By End-User

7. Europe Restriction Endonuclease Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End Type
    • 7.2.4. By Source
    • 7.2.5. By Cleavage Specificity
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Restriction Endonuclease Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Type
        • 7.4.1.2.2. By Application
        • 7.4.1.2.3. By End Type
        • 7.4.1.2.4. By Source
        • 7.4.1.2.5. By Cleavage Specificity
        • 7.4.1.2.6. By End-User
    • 7.4.2. Germany Restriction Endonuclease Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Type
        • 7.4.2.2.2. By Application
        • 7.4.2.2.3. By End Type
        • 7.4.2.2.4. By Source
        • 7.4.2.2.5. By Cleavage Specificity
        • 7.4.2.2.6. By End-User
    • 7.4.3. United Kingdom Restriction Endonuclease Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Type
        • 7.4.3.2.2. By Application
        • 7.4.3.2.3. By End Type
        • 7.4.3.2.4. By Source
        • 7.4.3.2.5. By Cleavage Specificity
        • 7.4.3.2.6. By End-User
    • 7.4.4. Italy Restriction Endonuclease Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Type
        • 7.4.4.2.2. By Application
        • 7.4.4.2.3. By End Type
        • 7.4.4.2.4. By Source
        • 7.4.4.2.5. By Cleavage Specificity
        • 7.4.4.2.6. By End-User
    • 7.4.5. Spain Restriction Endonuclease Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Type
        • 7.4.5.2.2. By Application
        • 7.4.5.2.3. By End Type
        • 7.4.5.2.4. By Source
        • 7.4.5.2.5. By Cleavage Specificity
        • 7.4.5.2.6. By End-User

8. North America Restriction Endonuclease Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End Type
    • 8.2.4. By Source
    • 8.2.5. By Cleavage Specificity
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Restriction Endonuclease Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Type
        • 8.4.1.2.2. By Application
        • 8.4.1.2.3. By End Type
        • 8.4.1.2.4. By Source
        • 8.4.1.2.5. By Cleavage Specificity
        • 8.4.1.2.6. By End-User
    • 8.4.2. Mexico Restriction Endonuclease Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Type
        • 8.4.2.2.2. By Application
        • 8.4.2.2.3. By End Type
        • 8.4.2.2.4. By Source
        • 8.4.2.2.5. By Cleavage Specificity
        • 8.4.2.2.6. By End-User
    • 8.4.3. Canada Restriction Endonuclease Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Type
        • 8.4.3.2.2. By Application
        • 8.4.3.2.3. By End Type
        • 8.4.3.2.4. By Source
        • 8.4.3.2.5. By Cleavage Specificity
        • 8.4.3.2.6. By End-User

9. South America Restriction Endonuclease Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End Type
    • 9.2.4. By Source
    • 9.2.5. By Cleavage Specificity
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Restriction Endonuclease Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Type
        • 9.4.1.2.2. By Application
        • 9.4.1.2.3. By End Type
        • 9.4.1.2.4. By Source
        • 9.4.1.2.5. By Cleavage Specificity
        • 9.4.1.2.6. By End-User
    • 9.4.2. Argentina Restriction Endonuclease Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Type
        • 9.4.2.2.2. By Application
        • 9.4.2.2.3. By End Type
        • 9.4.2.2.4. By Source
        • 9.4.2.2.5. By Cleavage Specificity
        • 9.4.2.2.6. By End-User
    • 9.4.3. Colombia Restriction Endonuclease Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Type
        • 9.4.3.2.2. By Application
        • 9.4.3.2.3. By End Type
        • 9.4.3.2.4. By Source
        • 9.4.3.2.5. By Cleavage Specificity
        • 9.4.3.2.6. By End-User

10. Middle East and Africa Restriction Endonuclease Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End Type
    • 10.2.4. By Source
    • 10.2.5. By Cleavage Specificity
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Restriction Endonuclease Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Type
        • 10.4.1.2.2. By Application
        • 10.4.1.2.3. By End Type
        • 10.4.1.2.4. By Source
        • 10.4.1.2.5. By Cleavage Specificity
        • 10.4.1.2.6. By End-User
    • 10.4.2. Saudi Arabia Restriction Endonuclease Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Type
        • 10.4.2.2.2. By Application
        • 10.4.2.2.3. By End Type
        • 10.4.2.2.4. By Source
        • 10.4.2.2.5. By Cleavage Specificity
        • 10.4.2.2.6. By End-User
    • 10.4.3. UAE Restriction Endonuclease Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Type
        • 10.4.3.2.2. By Application
        • 10.4.3.2.3. By End Type
        • 10.4.3.2.4. By Source
        • 10.4.3.2.5. By Cleavage Specificity
        • 10.4.3.2.6. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. New England Biolabs
    • 13.2.2. Thermo Fisher Scientific
    • 13.2.3. Takara Bio
    • 13.2.4. Sigma-Aldrich
    • 13.2.5. Illumina
    • 13.2.6. Agilent Technologies
    • 13.2.7. Promega
    • 13.2.8. Jena Biosciences
    • 13.2.9. Genetix Biotech Asia Pvt. Ltd.
    • 13.2.10. Roche
    • 13.2.11. Merck
    • 13.2.12. Pfizer
    • 13.2.13. Amgen
    • 13.2.14. Vertex Pharmaceuticals
    • 13.2.15. BioMarin Pharmaceutical
    • 13.2.16. PerkinElmer
    • 13.2.17. Abcam
    • 13.2.18. Abbexa
    • 13.2.19. Sisco Research Laboratories Pvt Ltd
    • 13.2.20. Nippon Gene

14. Strategic Recommendations

15. About Us & Disclaimer